Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tays Hernandez-Garcia"'
Autor:
Thailin Lao-Gonzalez, Alexi Bueno-Soler, Arnelys Duran-Hernandez, Katya Sosa-Aguiar, Luis Eduardo Hinojosa-Puerta, Tays Hernandez-Garcia, Kathya Rashida de la Luz-Hernandez, Julio Palacios-Oliva, Tammy Boggiano-Ayo
Publikováno v:
AMB Express, Vol 11, Iss 1, Pp 1-17 (2021)
Abstract The high prices of biopharmaceuticals or biologics used in the treatment of many diseases limit the access of patients to these novel therapies. One example is the monoclonal antibody trastuzumab, successfully used for breast cancer treatmen
Externí odkaz:
https://doaj.org/article/26d433c34aff46828e819f5825cff740
Autor:
Franciscary Pi-Estopinan, Jorman Rubino-Moreno, Mayte Amoroto-Roig, Maria Teresa Perez-Guevara, Yury Valdés-Balbín, Laura M. Rodríguez-Noda, Marisel Martinez-Perez, Meiby de la Caridad Rodriguez-Gonzalez, Carmen M Valenzuela-Silva, Dagmar García-Rivera, Rolando Ochoa-Azze, Maura Tamayo-Rodriguez, Raul Gonzalez-Mugica, Vicente Verez-Bencomo, Yanet Chappi-Estevez, Yanet Climent-Ruiz, Belinda Sanchez-Ramirez, Beatriz Paredes-Moreno, Anamary Suarez-Batista, Gretchen Bergado-Baez, Tays Hernandez-Garcia, Alina Díaz-Machado, Alis Martín-Trujillo, Sonia Pérez-Rodríguez, Rocmira Perez-Nicado, Guang-Wu Chen, Marta Dubed-Echevarría, Carlos A. González-Delgado
Publikováno v:
Vaccine. 40:2068-2075
BackgroundThe Receptor Binding Domain (RBD) of the SARS-CoV-2 spike protein is the target for many COVID-19 vaccines. Here we report results for phase 1 clinical trial of two COVID-19 vaccine candidates based on recombinant dimeric RBD (d-RBD).Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b445b9be96c36bcec3631c8577e62bff
https://doi.org/10.1016/j.vaccine.2022.02.029
https://doi.org/10.1016/j.vaccine.2022.02.029
Autor:
Eduardo Ojito Magaz, Daniel G. Rivera, Ariel Palenzuela Diaz, Yanelda Garcia Vega, Leslihana Verdecia Sanchez, Tammy Boggiano Ayo, Meybis Rodriguez Gonzalez, Belinda Sánchez Ramírez, Anitza Fraga Quintero, Ivis Mendoza Hernandez, Yury Valdés Balbin, Franciscary Pi Estopinan, Guang-Wu Chen, Beatriz Perez Masson, Yanet Climent Ruiz, Sonsire Fernandez Castillo, Gretchen Bergado Báez, Otto Cruz Sui, Beatriz Paredes Moreno, Carmen Valenzuela Silva, Tays Hernandez Garcia, Gerardo Baro Roman, Dagmar García Rivera, Darielys Santana Mederos, Laura Rodriguez Noda, Vicente Verez Bencomo, Ubel Ramirez Gonzalez, Rocmira Perez Nicado, María Eugenia Toledo-Romaní, Raul Gonzalez Mugica, Majela Garcia Montero
BackgroundSOBERANA 02 is a COVID-19 conjugate vaccine candidate based on SARS-CoV-2 recombinant RBD conjugated to tetanus toxoid. SOBERANA Plus antigen is dimeric-RBD. Here we report safety, reactogenicity and immunogenicity from phase I and IIa clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::585980601f45319168ec11e934bb3723
https://doi.org/10.1101/2021.11.14.21266309
https://doi.org/10.1101/2021.11.14.21266309
Autor:
Vicente Verez-Bencomo, Kalet Leon-Monzon, Yaima Zuniga-Rosales, Yanet Jerez-Barcelo, Yury Valdés-Balbín, Carmen Valenzuela-Silva, Marianniz Diaz-Hernandez, Yanet Climent-Ruiz, Juliet Enriquez-Puertas, Maria de los A. Garcia-Garcia, Delia Porto-Gonzalez, Raul Gonzalez-Mugica, Dagmar García-Rivera, Belinda Sanchez-Ramirez, Rocmira Perez-Nicado, Guang-Wu Chen, Pedro Pablo Guerra-Chaviano, Luis Herrera Martinez, Mireida Rodriguez-Acosta, Arturo Chang-Monteagudo, Tays Hernandez-Garcia, Rolando Ochoa-Azze, Rinaldo Puga-Gomez, Luis Dairon Rodríguez-Prieto, Ivette Orosa-Vazquez, Laura Ruiz-Villegas, Yenisey Triana-Marrero, Enrique Noa-Romero, Beatriz Marcheco-Teruel, Consuelo Macías-Abraham, Laura M. Rodríguez-Noda
We evaluated response to a single dose of the FINLAY-FR-1A recombinant dimeric-RBD base vaccine during a phase I clinical trial with 30 COVID-19 convalescents, to test its capacity for boosting natural immunity. This short report shows: a) an excelle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d49b54584eb53e0bda49ce6494529dce
https://doi.org/10.1101/2021.02.22.21252091
https://doi.org/10.1101/2021.02.22.21252091
Autor:
Arnelys Duran-Hernandez, Tammy Boggiano-Ayo, Luis Eduardo Hinojosa-Puerta, Kathya Rashida de la Luz-Hernandez, Tays Hernandez-Garcia, Katya Sosa-Aguiar, Alexi Bueno-Soler, Julio Palacios-Oliva, Thailin Lao-Gonzalez
Publikováno v:
AMB Express
AMB Express, Vol 11, Iss 1, Pp 1-17 (2021)
AMB Express, Vol 11, Iss 1, Pp 1-17 (2021)
The high prices of biopharmaceuticals or biologics used in the treatment of many diseases limit the access of patients to these novel therapies. One example is the monoclonal antibody trastuzumab, successfully used for breast cancer treatment. An eco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227e3dbd476f1db39f9186df29157db8
https://doi.org/10.21203/rs.3.rs-36824/v2
https://doi.org/10.21203/rs.3.rs-36824/v2
Autor:
Delia Porto-Gonzalez, Dagmar García-Rivera, Laura M. Rodríguez-Noda, Marianniz Diaz-Hernandez, Yanet Climent-Ruiz, Vicente Verez-Bencomo, Mireida Rodriguez-Acosta, Enrique Noa-Romero, Belinda Sanchez-Ramirez, Arturo Chang-Monteagudo, Pedro Pablo Guerra-Chaviano, Rolando Ochoa-Azze, Carmen Valenzuela-Silva, Olivia Fernández-Medina, Anet Valdes-Zayas, Yanet Jerez-Barcelo, Tays Hernandez-Garcia, Rocmira Perez-Nicado, Beatriz Marcheco-Teruel, Yenisey Triana-Marrero, Guang-Wu Chen, Laura Ruiz-Villegas, Rinaldo Puga-Gomez, Luis Dairon Rodríguez-Prieto, Maria de los A. Garcia-Garcia, Consuelo Macías-Abraham, Yury Valdés-Balbín, Juliet Enriquez-Puertas, Ivette Orosa-Vazquez, Yaíma Zúñiga-Rosales, Luis Herrera-Martínez
Publikováno v:
The Lancet Regional Health. Americas, Vol 4, Iss, Pp 100079-(2021)
Lancet Regional Health. Americas
Lancet Regional Health. Americas
Background: As a first step towards a vaccine protecting COVID-19 convalescents from reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial. Methods: Thirty COVID-19 convalescents aged 22-57 years were studied: convalescents of mild COVID
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::469c1a80321831634d0a584123ac6c00
https://doi.org/10.1016/j.lana.2021.100079
https://doi.org/10.1016/j.lana.2021.100079
Autor:
Rinaldo Puga-Gómez, Yariset Ricardo-Delgado, Chaumey Rojas-Iriarte, Leyanis Céspedes-Henriquez, Misleidys Piedra-Bello, Dania Vega-Mendoza, Noelvia Pestana Pérez, Beatriz Paredes-Moreno, Meiby Rodríguez-González, Carmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Laura Rodríguez-Noda, Rocmira Pérez-Nicado, Raul González-Mugica, Tays Hernández-García, Talía Fundora-Barrios, Martha Dubet Echevarría, Juliet María Enriquez-Puertas, Yenicet Infante-Hernández, Ariel Palenzuela-Díaz, Evelyn Gato-Orozco, Yanet Chappi-Estévez, Julio Cesar Francisco-Pérez, Miladi Suarez-Martinez, Ismavy C. Castillo-Quintana, Sonsire Fernandez-Castillo, Yanet Climent-Ruiz, Darielys Santana-Mederos, Yanelda García-Vega, María Eugenia Toledo-Romani, Delaram Doroud, Alireza Biglari, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Vérez-Bencomo, María Elena Mesa-Herrera, Yarmila García-Cristiá, Leonor Verdecia-Sánchez, Rafael del Valle Rodríguez, Yudalvies Oquendo-de la Cruz, Daysi Álvarez-Montalvo, Randy Grillo-Fortún, Liset López-González, Omaida Fonte Galindo, Yeseni Reyes-González, Ana Beatriz González-Álvarez, Linet Gorrita-Mora, Rodrigo Valera-Fernández, Ivis Ontivero-Pino, Marisel Martínez-Pérez, Esperanza Caballero-Gonzalez, Aniurka Garcés-Hechavarría, Dayle Martínez-Bedoya, Maite Medina-Nápoles, Yeney Regla Domínguez-Pentón, Yadira Cazañas-Quintana, Thais Fundora Barrios, Diana R. Hernández Fernández, Gretchen Bergado-Báez, Ivette Orosa-Vazquez, Franciscary Pi-Estopiñan, Marianniz Díaz-Hernández, Otto Cruz-Sui, Enrique Noa-Romero, Arilia García-López, Sandra Rivadereira Muro, Gerardo Baro-Roman
Publikováno v:
International Journal of Infectious Diseases, Vol 126, Iss , Pp 164-173 (2023)
Objectives: To evaluate a heterologous vaccination scheme in children 3-18 years old (y/o) combining two SARS-CoV-2r- receptor binding domain (RBD)protein vaccines. Methods: A phase I/II open-label, adaptive, and multicenter trial evaluated the safet
Externí odkaz:
https://doaj.org/article/88ee0659b0bf4cf3888a8d4fcd8fc08e
Autor:
Axel Ullrich, Rolando Perez Rodriguez, Tays Hernandez Garcia, Belinda Sánchez Ramírez, Greta Garrido Hidalgo, Luis E. Fernández, Eduardo Raul Suarez Pestana
Publikováno v:
International Journal of Cancer. 119:2190-2199
The epidermal growth factor receptor (EGFR) plays a central role in regulating neoplastic processes. The EGFR overexpression in many human epithelial tumors has been correlated with disease progression and bad prognosis. Passive EGFR-directed immunot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e6c7f6181ffa8399a4da1eb80804e0c
https://doi.org/10.1002/ijc.22085
https://doi.org/10.1002/ijc.22085
Autor:
Arturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Consuelo Macías-Abraham, Laura Rodríguez-Noda, Carmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Rocmira Perez-Nicado, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María de los Ángeles García-García, Yanet Jerez-Barceló, Yenisey Triana-Marrero, Laura Ruiz-Villegas, Luis Dairon Rodríguez-Prieto, Rinaldo Puga-Gómez, Pedro Pablo Guerra-Chaviano, Yaíma Zúñiga-Rosales, Beatriz Marcheco-Teruel, Mireida Rodríguez-Acosta, Enrique Noa-Romero, Juliet Enríquez-Puertas, Delia Porto-González, Olivia Fernández-Medina, Anet Valdés-Zayas, Guang-Wu Chen, Luís Herrera-Martínez, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Verez-Bencomo
Publikováno v:
The Lancet Regional Health. Americas, Vol 4, Iss , Pp 100079- (2021)
Background: As a first step towards a vaccine protecting COVID-19 convalescents from reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial. Methods: Thirty COVID-19 convalescents aged 22-57 years were studied: convalescents of mild COVID
Externí odkaz:
https://doaj.org/article/54ac04bcc70849c995125a973cce9fdb